Kieć-Kononowicz K, Stypuła E, Krupińska J, Cebo B
Pol J Pharmacol Pharm. 1985 Sep-Oct;37(5):693-9.
5,5-Diphenylhydantoin derivatives containing at the position 3 aminoalkyl (1, 2, 4, 5), aminohydroxyalkyl (3) and amide (6, 8) groups were synthesized. The compounds, given in a dose of 50 mg/kg, did not affect cardiac bioelectric activity and, in contrast to diphenylhydantoin, did not possess the antiarrhythmic properties and did not protect against pentetrazol seizures.
